Nafsika Forte
- Molecular Biology
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Organic Chemistry top 10%
- Hematology
- Co-authors
- James R. BakerVijay ChudasamaCyrille S. KoundeEdward W. TateMaria M. ShchepinovaMarı́a ManeiroMaurício MoraisKersti Karu
- Topics
- Monoclonal and Polyclonal Antibodies Research (7 papers)HER2/EGFR in Cancer Research (6 papers)Chemical Synthesis and Analysis (5 papers)
- Partner nations
- United KingdomPortugalUnited States
In The Last Decade
Nafsika Forte
13 papers receiving 585 citations
Hit Papers
Peers
Comparison fields: 5 of 47
- Molecular Biology 420
- Oncology 297
- Radiology, Nuclear Medicine and Imaging 222
- Organic Chemistry 156
- Hematology 68
Countries citing papers authored by Nafsika Forte
This map shows the geographic impact of Nafsika Forte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nafsika Forte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nafsika Forte more than expected).
Fields of papers citing papers by Nafsika Forte
This network shows the impact of papers produced by Nafsika Forte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nafsika Forte. The network helps show where Nafsika Forte may publish in the future.
Co-authorship network of co-authors of Nafsika Forte
This figure shows the co-authorship network connecting the top 25 collaborators of Nafsika Forte. A scholar is included among the top collaborators of Nafsika Forte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nafsika Forte. Nafsika Forte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 33 | |
| 3 | 8 | |
| 4 | 12 | |
| 5 | 75 | |
| 6 | 3 | |
| 7 | 24 | |
| 8 | Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4breakdown → | 242 |
| 9 | 19 | |
| 10 | 11 | |
| 11 | 51 | |
| 12 | 45 | |
| 13 | 59 |
About Nafsika Forte
Nafsika Forte is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, having authored 13 papers that have together received 595 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Oncology (297 citations), Radiology, Nuclear Medicine and Imaging (222 citations) and Molecular Biology (420 citations). Nafsika Forte has collaborated with scholars based in United Kingdom, Portugal and United States. Frequent co-authors include James R. Baker, Vijay Chudasama, Cyrille S. Kounde, Edward W. Tate, Maria M. Shchepinova, Marı́a Maneiro, Maurício Morais, Kersti Karu, João P. M. Nunes and Stephen Caddick. Their work appears in journals such as Journal of the American Chemical Society, Chemical Communications and Chemical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.